Finance

Beta
Lists
603233:SHA
Dashenlin Pharmaceutical Group Co Ltd
CN¥16.06
-0.12%
(-0.020) 1D
Jun 5, 10:35:22 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603233...
Open
CN¥16.19
High
CN¥16.39
Low
CN¥15.96
Mkt. cap
18.44B
Avg. vol.
6.96M
Volume
2.17M
P/E ratio
14.19
52-wk high
CN¥21.78
52-wk low
CN¥15.34
EPS
CN¥1.13
Shares outstanding
400.01M
No. of employees
41K
Open
CN¥16.19
High
CN¥16.39
Low
CN¥15.96
Mkt. cap
18.44B
Avg. vol.
6.96M
Volume
2.17M
P/E ratio
14.19
52-wk high
CN¥21.78
52-wk low
CN¥15.34
EPS
CN¥1.13
Shares outstanding
400.01M
No. of employees
41K
News stories
From sources across the web
About Dashenlin Pharmaceutical Group Co Ltd
CEO-
Employees41.1K
FoundedFeb 12, 1999
Headquarters-
SectorDrug
Websitedslyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.57B
6.55B
7.43B
6.97B
Cost of goods sold
4.28B
4.28B
5.01B
4.46B
Cost of revenue
4.28B
4.28B
5.01B
4.46B
Research and development expenses
20.59M
16.38M
-4.51M
9.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.76B
1.77B
1.95B
1.75B
Operating expense
1.79B
1.81B
2.04B
1.78B
Total operating expenses
6.07B
6.09B
7.05B
6.24B
Operating income
499.83M
458.77M
384.54M
733.21M
Other non operating income
-4.32M
-21.09M
-641.08K
-7.75M
EBT including unusual items
474.43M
398.31M
327.29M
707.02M
EBT excluding unusual items
460.77M
406.90M
360.61M
707.78M
Income tax expense
115.00M
95.80M
128.00M
163.45M
Effective tax rate
24.24%
24.05%
39.11%
23.12%
Other operating expenses
9.12M
21.41M
73.22M
22.65M
Net income
338.17M
282.83M
154.25M
511.14M
Net profit margin
5.15%
4.32%
2.07%
7.33%
Earnings per share
-
-
-
0.45
Interest and investment income
15.69M
15.03M
17.56M
17.38M
Interest expense
-50.42M
-45.81M
-40.14M
-35.06M
Net interest expenses
-34.73M
-30.78M
-22.59M
-17.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
572.98M
854.65M
451.17M
799.84M
Gain or loss from assets sale
-482.86K
482.86K
-14.70M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer